New York Laws
Article 131 - Medicine
6527 - Special Provisions.

(a) administering immunizations.
(b) the emergency treatment of anaphylaxis.
(c) administering purified protein derivative (PPD) tests or other
tests to detect or screen for tuberculosis infections.
(d) administering tests to determine the presence of the human
immunodeficiency virus.
(e) administering tests to determine the presence of the hepatitis C
virus.
(f) the urgent or emergency treatment of opioid related overdose or
suspected opioid related overdose.
(g) screening of persons at increased risk of syphilis, gonorrhea and
chlamydia.
* (h) administering tests to determine the presence of COVID-19 or its
antibodies or influenza virus.
* NB Repealed April 9, 2024
(i) administering electrocardiogram tests to detect signs and symptoms
of acute coronary syndrome.
(j) administering point-of-care blood glucose tests to evaluate acute
mental status changes in persons with suspected hypoglycemia.
(k) administering tests and intravenous lines to persons that meet
severe sepsis and septic shock criteria.
(l) administering tests to determine pregnancy.
7. A licensed physician may prescribe and order a patient specific
order or non-patient specific regimen to a licensed pharmacist, pursuant
to regulations promulgated by the commissioner, and consistent with the
public health law, for: (a) administering immunizations to prevent
influenza to patients two years of age or older; and (b) administering
immunizations to prevent pneumococcal, acute herpes zoster, hepatitis A,
hepatitis B, human papillomavirus, measles, mumps, rubella, varicella,
COVID-19, meningococcal, tetanus, diphtheria or pertussis disease and
medications required for emergency treatment of anaphylaxis to patients
eighteen years of age or older; and (c) administering other
immunizations recommended by the advisory committee on immunization
practices of the centers for disease control and prevention for patients
eighteen years of age or older if the commissioner of health in
consultation with the commissioner determines that an immunization: (i)
(A) may be safely administered by a licensed pharmacist within their
lawful scope of practice; and (B) is needed to prevent the transmission
of a reportable communicable disease that is prevalent in New York
state; or (ii) is a recommended immunization for such patients who: (A)
meet age requirements, (B) lack documentation of such immunization, (C)
lack evidence of past infection, or (D) have an additional risk factor
or another indication as recommended by the advisory committee on
immunization practices of the centers for disease control and
prevention. Nothing in this subdivision shall authorize unlicensed
persons to administer immunizations, vaccines or other drugs.
7-a. A licensed physician may prescribe and order a patient specific
order or non-patient specific order to a licensed pharmacist, pursuant
to regulations promulgated by the commissioner in consultation with the
commissioner of health, and consistent with the public health law, for
dispensing up to a seven day starter pack of HIV post-exposure

prophylaxis for the purpose of preventing human immunodeficiency virus
infection following a potential human immunodeficiency virus exposure.
8. Nothing in this article shall prohibit the provision of
psychotherapy as defined in subdivision two of section eighty-four
hundred one of this title to the extent permissible within the scope of
practice of medicine, by any not-for-profit corporation or education
corporation providing services within the state of New York and
operating under a waiver pursuant to section sixty-five hundred three-a
of this title, provided that such entities offering such psychotherapy
services shall only provide such services through an individual
appropriately licensed or otherwise authorized to provide such services
or a professional entity authorized by law to provide such services.
9. (a) Nothing in this article shall be construed to affect or prevent
a person in training or trained and deemed qualified by a supervising
licensed physician, to assist the licensed physician in the care of a
patient for the purpose of instilling mydriatic or cycloplegic eye drops
and anesthetic eye drops in conjunction with such dilating drops to the
surface of the eye of a patient, provided that the person instilling
such eye drops is:
(i) under the on-site supervision of a supervising licensed physician;
(ii) at least eighteen years of age; and
(iii) complies with standards issued by the department.
(b) The supervising licensed physician shall submit a form prescribed
by the department detailing the identity of each person instilling
mydriatic or cycloplegic eye drops and anesthetic eye drops in
conjunction with such dilating drops to the surface of the eye of a
patient, under his or her supervision, attesting to compliance with the
above requirements.
(c) The supervising licensed physician's use of any such person
pursuant to the terms of this subdivision shall be undertaken with
professional judgment in order to ensure the safety and well-being of
the patient. Such use shall subject the licensed physician to the full
disciplinary and regulatory authority of the office of professional
medical conduct and the board of regents. The licensed physician must
notify the patient or the patient's designated health care surrogate
that the licensed physician may utilize the services of an individual to
administer certain eye drops and must provide the patient or the
patient's designated health care surrogate the opportunity to refuse the
licensed physician's plan to utilize such person.
10. A licensed physician may prescribe and order a
non-patient-specific regimen to a licensed pharmacist, for insulin and
related supplies pursuant to section sixty-eight hundred one of this
title.
* 11. A licensed physician may prescribe and order a non-patient
specific order to a pharmacist licensed and located in the state,
pursuant to regulations promulgated by the commissioner, and consistent
with section sixty-eight hundred one of this title, for dispensing
self-administered hormonal contraceptives as defined in section
sixty-eight hundred two of this title.
* NB Effective November 2, 2024